Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07316270 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

SAfety and eFfectiveness of cathetER Ablation for Atrial Fibrillation With Intracranial Hemorrhage (SAFER-AF)

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria expanded, about 7 words
    • Secondary endpoints revised (9)
    • Study title revised
    • Study description expanded, about 2 words
    v3
  2. Recruitment opened
    • Start date changed from estimate of Jan 2026 to May 6, 2026
    • Site details revised at 7 of 7 sites
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
SAFER-AF is an investigator-initiated, multicenter, open-label, parallel-group trial comparing catheter ablation versus usual care in patients with atrial fibrillation and intracranial hemorrhage.
Trial Details
NCT Number NCT07316270
Lead Sponsor Beijing Anzhen Hospital
Conditions
(from sponsor)		 AF - Atrial Fibrillation, Intracranial Hemorrhage, Spontaneous
Related terms Atrial Fibrillation, Intracranial Hemorrhages
Enrollment 646 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov